93/152/EEC: Commission Decision of 8 February 1993 laying down the criteria for vaccines to be used against Newcastle disease in the context of routine vaccination programmes

• Articles: 3

Article 1

For the use in routine vaccination programmes:

(a) live attenuated Newcastle disease vaccines shall be prepared from a Newcastle disease virus strain for which the master seed has been tested and shown to have an intracerebral pathogenicity index (ICPI) of:

(i) less than 0,4 if not less than 107 EID50 are administrated to each bird in the ICPI test;

or

(ii) less than 0,5 if not less than 108 EID50 are administered to each bird, in the ICPI test;

(b) inactivated Newcastle disease vaccines shall be prepared from a Newcastle disease virus strain for which the Master Seed has been tested and shown to have an intracerebral pathogenicity index (ICPI) of less than 0,7 if not less than 108 EID50 are administered to each bird in the ICPI test.

Article 2

The present Decision shall apply from 1 January 1995.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 8 February 1993.

For the Commission

René STEICHEN

Member of the Commission

(1) OJ No L 303, 31. 10. 1990, p. 6.

(2) OJ No L 268, 14. 9. 1992, p. 54.